Carl Lawyer
- Co-authors
- Theresa M. BoleyMisako WatabeKounosuke WatabeMitchell J. MageeJoseph HenkleStephen R. HazelriggLanie E. EagletonSudha K. Pai
- Topics
- Antimicrobial Peptides and Activities (5 papers)Pediatric health and respiratory diseases (3 papers)Respiratory and Cough-Related Research (2 papers)
- Partner nations
- United States
In The Last Decade
Carl Lawyer
17 papers receiving 440 citations
Peers
Comparison fields: 5 of 71
- Pulmonary and Respiratory Medicine 165
- Microbiology 160
- Molecular Biology 145
- Surgery 61
- Immunology 60
Countries citing papers authored by Carl Lawyer
This map shows the geographic impact of Carl Lawyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Lawyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Lawyer more than expected).
Fields of papers citing papers by Carl Lawyer
This network shows the impact of papers produced by Carl Lawyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Lawyer. The network helps show where Carl Lawyer may publish in the future.
Co-authorship network of co-authors of Carl Lawyer
This figure shows the co-authorship network connecting the top 25 collaborators of Carl Lawyer. A scholar is included among the top collaborators of Carl Lawyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Lawyer. Carl Lawyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Nuclear localization of HBD-1 in human keratinocytes. | 12 |
| 2 | Modulation of the complement system by human beta-defensin 2. | 18 |
| 3 | 7 | |
| 4 | 33 | |
| 5 | 94 | |
| 6 | 5 | |
| 7 | 15 | |
| 8 | 42 | |
| 9 | 133 | |
| 10 | A synthetic form of tracheal antimicrobial peptide has both bactericidal and antifungal activities. | 3 |
| 11 | Potential in vitro activity of Kutapressin against Epstein-Barr virus. | 0 |
| 12 | Antiviral activity in vitro of Kutapressin against human herpesvirus-6. | 3 |
| 13 | 2 | |
| 14 | 1 | |
| 15 | 37 | |
| 16 | 2 | |
| 17 | 8 | |
| 18 | 49 |
About Carl Lawyer
Carl Lawyer is a scholar working on Microbiology, Emergency Medical Services and Behavioral Neuroscience, having authored 18 papers that have together received 464 indexed citations. Recurring topics across this work include Antimicrobial Peptides and Activities (5 papers), Pediatric health and respiratory diseases (3 papers) and Respiratory and Cough-Related Research (2 papers). The work is most often cited by research in Microbiology (160 citations), Pulmonary and Respiratory Medicine (165 citations) and Anesthesiology and Pain Medicine (24 citations). Carl Lawyer has collaborated with scholars based in United States. Frequent co-authors include Theresa M. Boley, Misako Watabe, Kounosuke Watabe, Mitchell J. Magee, Joseph Henkle, Stephen R. Hazelrigg, Lanie E. Eagleton, Sudha K. Pai, Tomoyuki Mashimo and P T Borgia. Their work appears in journals such as Annals of Internal Medicine, Clinical Infectious Diseases and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.